TY - JOUR
T1 - Detection of Mild Cognitive Impairment from Language Markers with Crossmodal Augmentation
AU - Liu, Guangliang
AU - Xue, Zhiyu
AU - Zhan, Liang
AU - Dodge, Hiroko H.
AU - Zhou, Jiayu
N1 - Funding Information:
This material is based in part upon work supported by the National Science Foundation under Grant IIS-2212174, IIS-1749940, Office of Naval Research N00014-20-1-2382, and National Institute on Aging (NIA) RF1AG072449, R01AG051628, and R01AG056102.
Publisher Copyright:
© 2022 The Authors.
PY - 2023
Y1 - 2023
N2 - Mild cognitive impairment is the prodromal stage of Alzheimers disease. Its detection has been a critical task for establishing cohort studies and developing therapeutic interventions for Alzheimers. Various types of markers have been developed for detection. For example, imaging markers from neuroimaging have shown great sensitivity, while its cost is still prohibitive for large-scale screening of early dementia. Recent advances from digital biomarkers, such as language markers, have provided an accessible and affordable alternative. While imaging markers give anatomical descriptions of the brain, language markers capture the behavior characteristics of early dementia subjects. Such differences suggest the benefits of auxiliary information from the imaging modality to improve the predictive power of unimodal predictive models based on language markers alone. However, one significant barrier to the joint analysis is that in typical cohorts, there are only very limited subjects that have both imaging and language modalities. To tackle this challenge, in this paper, we develop a novel crossmodal augmentation tool, which leverages auxiliary imaging information to improve the feature space of language markers so that a subject with only language markers can benefit from imaging information through the augmentation. Our experimental results show that the multi-modal predictive model trained with language markers and auxiliary imaging information significantly outperforms unimodal predictive models.
AB - Mild cognitive impairment is the prodromal stage of Alzheimers disease. Its detection has been a critical task for establishing cohort studies and developing therapeutic interventions for Alzheimers. Various types of markers have been developed for detection. For example, imaging markers from neuroimaging have shown great sensitivity, while its cost is still prohibitive for large-scale screening of early dementia. Recent advances from digital biomarkers, such as language markers, have provided an accessible and affordable alternative. While imaging markers give anatomical descriptions of the brain, language markers capture the behavior characteristics of early dementia subjects. Such differences suggest the benefits of auxiliary information from the imaging modality to improve the predictive power of unimodal predictive models based on language markers alone. However, one significant barrier to the joint analysis is that in typical cohorts, there are only very limited subjects that have both imaging and language modalities. To tackle this challenge, in this paper, we develop a novel crossmodal augmentation tool, which leverages auxiliary imaging information to improve the feature space of language markers so that a subject with only language markers can benefit from imaging information through the augmentation. Our experimental results show that the multi-modal predictive model trained with language markers and auxiliary imaging information significantly outperforms unimodal predictive models.
KW - Crossmodal Augmentation
KW - Mild Cognitive Impairment
KW - Multi-modality Analysis
UR - http://www.scopus.com/inward/record.url?scp=85144278742&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144278742&partnerID=8YFLogxK
U2 - 10.1142/9789811270611_0002
DO - 10.1142/9789811270611_0002
M3 - Conference article
C2 - 36540960
AN - SCOPUS:85144278742
SP - 7
EP - 18
JO - Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
JF - Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
SN - 2335-6936
IS - 2023
T2 - 28th Pacific Symposium on Biocomputing, PSB 2023
Y2 - 3 January 2023 through 7 January 2023
ER -